Clinical trial reportCancer medicinePublished
A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Cancer medicine
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Fever; Protein Kinase Inhibitors; Female; Clinical Trials, Phase II as Topic; Triple Negative Breast Neoplasms; Nivolumab; Immunotherapy; Solid Tumors; Tnbc; Phase Ib; Mivavotinib
- PubMed ID
- 38501219
- PubMed Central ID
- PMC10949085
- Open access
- Yes, open
- Added to directory
- Source checked